Alumis Inc logo

Alumis Inc

ALMS
Healthcare|Biotechnology|USA
$28.32
-1.96 (-6.48%)
Tangible Book
$4.06

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 8.44, 23.48, 164.88, 430.72, 920.83 ], "ebit_estimate": [ -382.53, -390.81, -288.77, -123.42, 394.18 ], "ebitda_estimate": [ -377.03, -343.19, -136.97, null, null ], "net_income_estimate": [ -371.27, -377.46, -277.75, -107.62, 417.95 ], "per_share_eps_estimate": [ -2.83, -2.62, -1.88, -0.64, 1.62 ], "eps_nri_estimate": [ -2.85, -2.63, -1.74, -0.64, 1.62 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.18, 0.39, 0.78, null, null ], "pretax_income_estimate": [ -371.24, -382.75, -277.75, -107.65, 417.95 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -127.19, -174.56, -87.92, null, null ], "gross_margin_estimate": [ null, null, 90, 90, 90 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 17.5 ], "long_term_growth_rate_mean": 14.6, "long_term_revenue_growth_rate_mean": "97.37", "future_per_share_eps_estimate_growth": 12.52, "future_eps_nri_estimate_growth": 14.6, "future_revenue_estimate_growth": 97.37, "future_ebit_estimate_growth": 12.49, "future_ebitda_estimate_growth": 30.68, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -39.49, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 4.02, 1.78, 1.78, 0.6, 0.6, 4.6, 11.78 ], "ebit_estimate": [ -93.01, -95.37, -96.73, -97.2, -98.68, -96.57, -91.59 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -90.3, -92.52, -94.07, -92.89, -93.49, -90.41, -85.22 ], "per_share_eps_estimate": [ -0.72, -0.7, -0.69, -0.66, -0.66, -0.64, -0.59 ], "eps_nri_estimate": [ -0.73, -0.7, -0.69, -0.66, -0.66, -0.64, -0.59 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -90.3, -92.52, -94.19, -93.85, -95.41, -93.38, -88.88 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 14.6, "long_term_revenue_growth_rate_mean": "97.37", "future_per_share_eps_estimate_growth": 12.52, "future_eps_nri_estimate_growth": 14.6, "future_revenue_estimate_growth": 97.37, "future_ebit_estimate_growth": 12.49, "future_ebitda_estimate_growth": 30.68, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -39.49, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }